Daniel Q. Huang

Singapore

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

LINKED CONTENT This article is linked to Wijarnpreecha et al papers. To view these articles, visit https://doi.org/10.1111/apt.17424 and https://doi.org/10.1111/apt.17453

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (7)

Seng Gee Lim

SINGAPORE

View details

Beom Kyung Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

Jinho Jung

University of California, San Diego

UNITED STATES

View details

Vy Nguyen

Stanford University Medical Center

UNITED STATES

View details

Veeral Ajmera

University of California, San Diego

UNITED STATES

View details

Tarek Nayfeh

Assistant Professor of Medicine

Mayo Clinic

UNITED STATES

View details

Claude B. Sirlin

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Q. Huang

Research Interests

Contact this professor

Articles (11)

Global treatment rate and barriers to DAA therapy: A systematic review and meta-analysis of 146 studies and 1,760,352 HCV patients.

Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD

Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes

MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analyses

Editorial: clinical outcomes in lean <scp>NAFLD</scp>—the devil is in the details

Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology

Editorial: Will MRI‐PDFF become the new standard for steatosis assessment in NAFLD? Authors' reply

Global burden of hepatitis B virus: current status, missed opportunities and a call for action

Meta‐analysis: Prevalence of significant or advanced fibrosis in adults with alpha‐1‐antitrypsin deficiency

Global epidemiology of cirrhosis — aetiology, trends and predictions

Future <scp>anti‐HDV</scp> treatment strategies, including those aimed at <scp>HBV</scp> functional cure

Collaborators (7)

Seng Gee Lim

Beom Kyung Kim

Jinho Jung

Vy Nguyen

Veeral Ajmera

Tarek Nayfeh

Claude B. Sirlin

Make your next move.